About this Research Topic

Background

Although late-stage clinical attrition has been repeatedly highlighted as the most significant issue facing the pharmaceutical industry, the probability of technical success in the clinic is largely related to decisions made years earlier in the preclinical stages of R&D. It’s at these stages that decisions are made regarding the molecular target, modality of intervention, drug design and clinical candidate selection. Accordingly, model-informed drug development approaches that have proven useful in the clinic (e.g. PBPK, PKPD, QSP) are increasingly be leveraged to support decisions in the earlier, preclinical stages of R&D.

There have been numerous studies published to date about applying modeling and simulation techniques on various preclinical research topics in drug discovery. Among these preclinical modeling publications, only a few focus on decision making. Studies about modeling methodology per se (e.g., establishing a mechanistic but retrospective model to recapitulate clinical observations) are interesting and important, however it is also critical to test these modeling methods in decision-making scenarios (e.g., estimating required selectivity between on-target and off-target potency for a drug candidate based on translational modeling). Publishing model-informed decision-making case examples will allow us to better understand modeling’s impacts and limitations in the real-world drug discovery, and provide insights and guidance towards future preclinical modeling research. Under this topic, Frontiers in Pharmacology will promote publication of in silico studies that have an experimental component ( in vitro or in vivo approaches), which illustrates such efforts with an emphasis on how modeling and simulation is being used to advance hypothesis driven research and support decision making in preclinical research.

This Research Topic welcomes Original Research, Perspective, or Review article submissions that cover the following topics:

• Target evaluation: Model-based evaluation of therapeutic hypotheses as they relate to the molecular target or pathway of interest. Highlighting model-based assessments of potential efficacy and safety which led to decisions to either accelerate or discontinue investment in a target or pathway.
• Modality selection: Model-based prioritization of interventional modalities in disease (e.g. competitive, allosteric, covalent, mAb, multispecific mAbs, PROTACs, molecular glues DUBs, RNAi, etc.). Submissions should exemplify models which codify target/disease biology, molecular mechanism of action and the desired mechanistic/therapeutic response.
• Drug Design: Model-based guidance of drug design by providing a line of sight into a clinically relevant outcome (response, dose, therapeutic index). Submissions should highlight how modeling and simulation informed drug design through identification of desired properties or direct guidance regarding options for lead optimization.
• Candidate selection and early clinical development: Application of preclinical modeling and simulation to quantitatively predict aspects of human pharmacology and safety in support of candidate selection and early clinical trial design. Ideal examples would be those in which model-based predictions were particularly impactful in making the case for advancement to the clinic or significantly influenced the design of early, decision-making clinical trials.
• Preclinical modeling and simulation methods: Approaches of broad relevance to preclinical R&D. Models and methods should be described in enough detail to allow recapitulation of results. Ideally, one or more case examples will be provided to illustrate application to decision making. Anonymization of proprietary information (e.g. chemical structure) is acceptable so long as it does not prevent recapitulation of the proposed model.

Important note: In order for readers to understand the key modeling steps and to reproduce the results described in the article, authors are required to supply sufficient technical details (including example model code and datasets) either as supplementary information submitted with the main article, or archived in an appropriate public repository.

Topic editors Rui Li and Tristan S. Maurer are employed by Pfizer Inc. Topic Editor Alison Betts is employed by Applied BioMath. All other Topic Editors declare no competing interests with regards to the Research Topic subject.

Keywords: Drug Discovery, Modeling and Simulation, Decision-making, Preclinical-to-clinical translation

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Frequently asked questions

• What is a Research Topic?

  Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

  Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

• Why does Frontiers publish Research Topics? 

  The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

  Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

• Why are Research Topics important for journals?

  As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

  A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

• How do we ensure the quality of articles within Research Topics?

  Each Research Topic must be approved by the specialty chief editor, and it falls under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

  In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

• What are the benefits of publishing my article in a Research Topic?

  Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

  As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

  Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

   
• What types of articles can be published in a Research Topic?

  Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

  Check available article types here 

• Can I suggest a new Research Topic? 

  Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

  Suggest your topic here 

• Who leads a Research Topic? 

  A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

  The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

• What is the role of a topic editor?

  As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

   

  You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

• What support will I receive when editing a new Research Topic? 

  As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

• As a junior researcher, can I be involved in editing a Research Topic? 

  If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

• Can I get a certificate for editing a Research Topic?

  Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

• Who will I collaborate with?

  Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

• How long does it take to publish a Research Topic?

  As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

  Find out more about our Research Topics

• What fee support is available to authors publishing in a Research Topic?

  Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

  Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

• Will there be a printed version of my Research Topic?

  In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.